Javier Aznar
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 25
-
- Antibiotic Use and Resistance 13
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology 15
- Antimicrobial Resistance in Staphylococcus 13
- Microbiology top 2%
- Reproductive tract infections research 11
- Endocrinology top 2%
-
- Mycobacterium research and diagnosis 17
- Pneumonia and Respiratory Infections 11
-
- Antibiotics Pharmacokinetics and Efficacy 15
- Co-authors
- José-Carlos Palomares-SalasMarı́a José TorresMaría José Torres-SánchezChristian GortázarJerónimo PachónJoaquín VicenteEvelio J. PereaJosé Antonio Lepe
- Journals
- Journal of Antimicrobial Chemotherapy (8 papers)Clinical Microbiology and Infection (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)
- Partner nations
- SpainUnited StatesCzechia
In The Last Decade
Javier Aznar
98 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 113
- Molecular Medicine 562
- Applied Microbiology and Biotechnology 156
- Infectious Diseases 991
- Microbiology 231
- Endocrinology 174
Countries citing papers authored by Javier Aznar
This map shows the geographic impact of Javier Aznar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Aznar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Aznar more than expected).
Fields of papers citing papers by Javier Aznar
This network shows the impact of papers produced by Javier Aznar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Aznar. The network helps show where Javier Aznar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Javier Aznar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2019 | 33 | |
| 3 | Evolución de la sensibilidad y de los aislados productores de β-lactamasas de espectro extendido en microorganismos gramnegativos en el estudio SMART en España (2011-2015) | 2018 | 2 |
| 4 | 2018 | 6 | |
| 5 | 2018 | 6 | |
| 6 | 2016 | 18 | |
| 7 | 2016 | 11 | |
| 8 | 2013 | 15 | |
| 9 | Evaluación de un punto de corte farmacocinético-farmacodinámico para rifampicina en Acinetobacter baumannii mediante simulación de Monte-Carlo | 2012 | 3 |
| 10 | 2012 | 11 | |
| 11 | 2012 | 17 | |
| 12 | 2011 | 31 | |
| 13 | 2011 | 53 | |
| 14 | 2010 | 1 | |
| 15 | 2009 | 11 | |
| 16 | 2009 | 172 | |
| 17 | 2008 | 137 | |
| 18 | 1999 | 10 | |
| 19 | 1997 | 10 | |
| 20 | 1996 | 11 |
About Javier Aznar
Javier Aznar is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Microbiology, having authored 101 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (25 papers), Mycobacterium research and diagnosis (17 papers), Tuberculosis Research and Epidemiology (15 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers), Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotic Use and Resistance (13 papers), Reproductive tract infections research (11 papers) and Pneumonia and Respiratory Infections (11 papers). The work is most often cited by research in Molecular Medicine (562 citations), Applied Microbiology and Biotechnology (156 citations) and Infectious Diseases (991 citations). Javier Aznar has collaborated with scholars based in Spain, United States and Czechia. Frequent co-authors include José-Carlos Palomares-Salas, Marı́a José Torres, María José Torres-Sánchez, Christian Gortázar, Jerónimo Pachón, Joaquín Vicente, Evelio J. Perea, José Antonio Lepe, A Criado and José Garnacho‐Montero. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.